Hawaii · 2026 Regular Session · Concurrent Resolution

SCR 18: REQUESTING THE AUDITOR TO ASSESS THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION.

In committee Last action March 30, 2026: The committee on HHS deferred the measure.

Plain-language summary

SCR 18 is a concurrent resolution introduced in the Hawaii Senate on February 6, 2026. According to its official title, it concerns: REQUESTING THE AUDITOR TO ASSESS THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION. Primary sponsor: Kurt Fevella (Republican), Jarrett Keohokalole (Democratic). Most recent recorded action (March 30, 2026): The committee on HHS deferred the measure.

Sponsors

Primary sponsors: Kurt Fevella (Republican); Jarrett Keohokalole (Democratic).